Lonza Group AG (OTCMKTS:LZAGY – Get Free Report) saw a significant growth in short interest during the month of January. As of January 15th, there was short interest totalling 22,500 shares, a growth of 5,525.0% from the December 31st total of 400 shares. Based on an average daily volume of 85,500 shares, the days-to-cover ratio is currently 0.3 days.
Wall Street Analysts Forecast Growth
Several research firms recently weighed in on LZAGY. Redburn Atlantic upgraded Lonza Group to a “strong-buy” rating in a research report on Wednesday, November 27th. The Goldman Sachs Group raised Lonza Group to a “strong-buy” rating in a report on Wednesday, October 9th.
Get Our Latest Stock Analysis on Lonza Group
Lonza Group Trading Up 1.3 %
Lonza Group Company Profile
Lonza Group AG, together with its subsidiaries, supplies various products and services for pharmaceutical, biotech, and nutrition markets in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally. It operates through Biologics, Small Molecules, Cell & Gene, and Capsules & Health Ingredients segments.
Read More
- Five stocks we like better than Lonza Group
- 3 Healthcare Dividend Stocks to Buy
- Survey Reveals: Top 150 Best Coffee Shops for Remote Workers and Business Deals [2025]
- Earnings Per Share Calculator: How to Calculate EPS
- What Does the Future Hold for Eli Lilly?
- Stock Dividend Cuts Happen Are You Ready?
- Oracle Stock Drops Nearly 14% – Is Now the Time to Buy?
Receive News & Ratings for Lonza Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lonza Group and related companies with MarketBeat.com's FREE daily email newsletter.